Added to YB: 2026-08-11
Pitch date: 2026-07-08
TEM [bullish]
Tempus AI, Inc.
-3.3%
current return
Author Info
Outlier Capital is where I share my highest-conviction ideas, portfolio updates, and investment research. Sign up for the newsletter.
Company Info
Tempus AI, Inc. operates as a healthcare technology company in the United States. It offers the Tempus platform, a closed-loop, full-stack, bi-directional integrations between a clinician’s desktop and its laboratory diagnostic capabilities, analytics platform, and repository of multimodal data; and Hub, a clinical application for physicians and other healthcare providers for use in the diagnostics product line as an end-to-end application for healthcare providers for NGS tests.
Market Cap
$9.4B
Pitch Price
$56.94
Price Target
560.00 (+976%)
Dividend
N/A
EV/EBITDA
-53.12
P/E
-36.31
EV/Sales
7.00
Sector
Life Sciences Tools and Services
Category
growth
Healthcare & Biotechnology AI Thesis (I) – 5 Stocks with Credible 10x+ Potential: Tempus AI (TEM) – Multimodal Precision Medicine & Genomics AI Leader
TEM: Precision medicine leader w/ largest multimodal oncology dataset (clinical/genomic/imaging/outcomes) powering AI decision support & pharma apps. Q1'26 rev $348M (+36% YoY); FY26 guide raised to $1.59-1.60B (~25%), positive adj EBITDA trajectory. ~$56/shr, ~$10B cap. Data flywheel widens moat; 10x+ potential. Risks: competition, reimbursement, data privacy/regulatory.
Read full article (1 min)